← All trials
NCT04683146
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 10, 2021
- Primary completion
- Mar 24, 2021
- Completion date
- Jun 5, 2021
- First posted
- Dec 24, 2020
- Last posted
- Dec 24, 2020
- Enrollment
- 24
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Centro Ortopedico y Quirurgico del PieLead sponsor
- Universidad Complutense de MadridOverall official - principal investigator
- Centro Ortopedico y Quirurgico del PieReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.